dc.contributor.author | Celebi, Fahri | |
dc.contributor.author | Ertekin, ERHAN | |
dc.contributor.author | Tukel, Rasit | |
dc.contributor.author | Kok, Burcu Ece | |
dc.contributor.author | KOYUNCU, Ahmet | |
dc.date.accessioned | 2021-03-03T10:49:53Z | |
dc.date.available | 2021-03-03T10:49:53Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | KOYUNCU A., Celebi F., Ertekin E., Kok B. E. , Tukel R., "Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series", THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, cilt.7, sa.11, ss.241-247, 2017 | |
dc.identifier.issn | 2045-1253 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_24d01ec0-4425-4ad8-8ae0-265a79756759 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/29638 | |
dc.identifier.uri | https://doi.org/10.1177/2045125317714193 | |
dc.description.abstract | Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Psikiyatri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.title | Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series | |
dc.type | Makale | |
dc.relation.journal | THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | |
dc.contributor.department | Acad Social Phobia Ctr , , | |
dc.identifier.volume | 7 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 241 | |
dc.identifier.endpage | 247 | |
dc.contributor.firstauthorID | 20584 | |